02031nam a2200433Ia 4500001001200000003000800012006001900020007001500039008004100054020001500095020001800110020001800128040002100146035002100167050002400188245038500212260005800597300002300655504004100678533015200719650002600871650003100897650003700928650002800965650003500993650003201028650001901060650002701079655002901106700002401135700002001159700002201179710013201201710006801333710003601401710001701437856012601454999001701580ebr10606367CaPaEBRm        u        cr cn|||||||||120911s2012    dcua    sb    000 0 eng d  z0309224187  z9780309224185  z9780309224192  aCaPaEBRcCaPaEBR  a(OCoLC)81252859414aQH452.7b.E8 2012eb00aEvolution of translational omicsh[electronic resource] :blessons learned and the path forward /cCommittee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy ; Christine M. Micheel, Sharyl J. Nass, and Gilbert S. Omenn, editors ; Institutes of Medicine of the National Academies.  aWashington, D.C. :bNational Academies Press,cc2012.  axv, 338 p. :bill.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aGenomicsxTechnology. 0aGenomicsxData processing. 0aGenetic translationxTechnology. 0aBiomoleculesxAnalysis. 0aBiomoleculesxData processing. 0aBioinformaticsxTechnology. 0aBiotechnology. 0aData miningxAnalysis. 7aElectronic books.2local1 aMicheel, Christine.1 aNass, Sharyl J.1 aOmenn, Gilbert S.2 aInstitute of Medicine (U.S.).bCommittee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials.2 aInstitute of Medicine (U.S.).bBoard on Health Sciences Policy.2 aNational Academies Press (U.S.)2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10606367zAn electronic book accessible through the World Wide Web; click to view  c96735d96735